Add SubjectMark | Hide Original Post | Show Chart | Poster Summary |Cell Therapeutics (CTIC) | Stock Discussion Forums Share This Board

Moderated By: Regis McConnell -- (Not Moderated) -- Started: 8/4/1997 1:04:00 AM  Revision History This recent bio-pharmacuetical IPO, has very compelling 'small molecule' technology. Currently in phase II/III trials is a synthetic drug candidate, Lisobylline, for reducing mortality rates related to radiation/chemotherapy treatments. Here's a link.;-) cticseattle.com

Reply	Message Preview	From	Recs	Date
946	EMA CHMP gives Pixantrone the thumbs up! >>SEATTLE, Feb. 17, 2012 /PRNews	tuck	-	02/17/2012 11:33 AM
945	CTIC up 12% on high volume - what will today bring after this roller coaster wee	trumptowr	-	03/25/2010 09:02 AM
944	FDA Raises Concerns About Cell Therapeutics' Cancer Drug By Adam Feuerstein	kenhott	-	02/08/2010 09:57 AM
943	The split-adjusted share price is down 99.97% since Feb 2005, which is even wors	DewDiligence_on_SI	-	01/12/2009 03:49 AM
942	What gall. By Rami Grunbaum Deputy business editor and Seattle Times Business	Findit	-	01/12/2009 01:56 AM
941	DD thnx..	mlkr	-	12/03/2008 02:55 PM
940	…yet no move…strange! The explanation can be found here: investorshub.advfn.com	DewDiligence_on_SI	-	12/02/2008 04:18 PM
939	fast review status... made number 1 buy ranked stocks list of ZACK... yet no mov	mlkr	-	12/02/2008 03:47 PM
938	Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in	kenhott	-	11/12/2008 07:16 AM
937	You mean bonuses are a cash item?	tom pope	-	07/21/2008 10:30 AM
936	Cell Therapeutics says it's low on cash Who knew? :-)	DewDiligence_on_SI	-	07/21/2008 09:59 AM